2015
DOI: 10.1177/1545968315575612
|View full text |Cite
|
Sign up to set email alerts
|

The HAAPI (Home Arm Assistance Progression Initiative) Trial

Abstract: Background Geographical location, socioeconomic status and logistics surrounding transportation impede access of post-stroke individuals to comprehensive rehabilitative services. Robotic therapy may enhance telerehabilitation by delivering consistent and state-of-the art therapy while allowing for the remote monitoring and adjusting therapy for underserved populations. The Hand Mentor Pro (HMP), was incorporated within a home exercise program (HEP) to improve upper extremity functional capabilities post-stroke… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
98
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 97 publications
(103 citation statements)
references
References 51 publications
4
98
1
Order By: Relevance
“…Further, multiple baselines in a previous sample failed to show a change in scores due to repeated testing. 7 Nonetheless, the magnitude of change seen here is similar to the magnitudes of change seen in many other motor intervention studies at this later time point post stroke (for examples from recent studies see 4749 ) and to changes in routine outpatient care, 50 but is substantially smaller than magnitudes of change seen in interventions delivered earlier after stroke. 10, 51 The lack of a dose effect in this study highlights the importance of explicitly testing dose-response hypotheses with more than two dose groups in carefully controlled Phase II trials.…”
Section: Discussionsupporting
confidence: 80%
“…Further, multiple baselines in a previous sample failed to show a change in scores due to repeated testing. 7 Nonetheless, the magnitude of change seen here is similar to the magnitudes of change seen in many other motor intervention studies at this later time point post stroke (for examples from recent studies see 4749 ) and to changes in routine outpatient care, 50 but is substantially smaller than magnitudes of change seen in interventions delivered earlier after stroke. 10, 51 The lack of a dose effect in this study highlights the importance of explicitly testing dose-response hypotheses with more than two dose groups in carefully controlled Phase II trials.…”
Section: Discussionsupporting
confidence: 80%
“…The magnitude of change seen here was similar to the magnitudes of change seen in many other motor rehabilitation studies at this later time point post stroke (for examples from recent studies see 15-17 ) and to changes in routine outpatient care, 18 but is smaller than magnitudes of change seen earlier after stroke, 19,20 when the natural trajectory of recovery exerts a powerful beneficial effect. Modest changes were also seen with the secondary outcomes of self-reported performance measured with the Stroke Impact Scale – Hand Function subscale and the Canadian Occupational Performance Measure.…”
Section: Strokesupporting
confidence: 84%
“…The participants also showed clinically significant improvements in Action Reach Arm Test scores (18.7%, p = 0.01). A recent large randomized controlled trial compared the effects of the HM in combination with a home exercise program (HEP) with the effects of HEP alone on moderately impaired patients with stroke (as indicated by baseline FMA scores of 34.1 ± 12.1 and 33.3 ± 12.0, respectively) [46]. They found that the combination of HM and HEP and a dose equivalent HEP therapy alone were equally effective, suggesting that both traditional and HM augmented therapies are effective in improving UL outcomes.…”
Section: Discussionmentioning
confidence: 99%